Category: Partners

  • Auto Claim Specialists Wins Fight for Mandatory Right to Appraisal in Texas

    Auto Claim Specialists Wins Fight for Mandatory Right to Appraisal in Texas

    Throwing Stones to Take Down a Giant

    FORT WORTH, TX / ACCESS Newswire / June 23, 2025 / They said it couldn’t be done. They said it was impossible. No one believed the battle to require the Right to Appraisal be included in all Texas auto policies could be won – no one except Robert McDorman, founder of Auto Claim Specialists, whose devotion to ensuring the safety of roadways in the Lone Star State inspired him to take up a slingshot in this iteration of the classic “David versus Goliath” showdown.

    For nearly a decade, McDorman tirelessly led the charge to persuade lawmakers of the importance of mandatory appraisal rights, and his hard work has finally paid off – Senate Bill 458 has been adopted into the Texas Insurance Code and made law!

    The war against the Appraisal Clause began in 2015 when State Farm removed this vital consumer protection from their Texas policies. McDorman took up the mantle and began sounding the alarm through meetings with the Texas Department of Insurance (TDI) to alert them to the potential dangers that such an action presented to drivers and their roadways. Bills proposing mandatory appraisal rights were presented in the 2021 and 2023 sessions, but both times, the session ended before a conclusive vote; however, the third time was the charm!

    Senate 458, the 2025 iteration of this legislative initiative, was fast-tracked through the process, obtaining unanimous approval from both the Senate and the House during every review. That’s a far cry from eight years ago when “legislators didn’t believe there was a need for mandatory appraisal rights,” McDorman recalls. “They hadn’t heard anything about it and couldn’t be convinced that it was a problem that needed their attention.”

    Legislators’ disinterest did not dissuade him from his mission. McDorman continued to beat the drum for mandatory appraisal, meeting with TDI five times and appearing before various legislative committees a total of eight times to educate them on the impact of the Appraisal Clause. “Every time someone told me ‘no,’ I pushed forward. I refused to believe it was a waste of time.”

    His dogged determination ultimately attracted attention, leading TDI to acknowledge the need for legislators to “establish policy form appraisal guidance” in its 2022 Biennial Report, and in its Report to the 88th Texas Legislature, the Office of Public Insurance Counsel (OPIC) expressed increasing concern with “restrictions on appraisal in policy forms filed by top insurers [which] can adversely impact consumers, who buy insurance to make sure damage to their property will be repaired or replaced. Without appraisal, they may be forced to choose between accepting the insurer’s offer and paying out-of-pocket for any disputed amount or taking on the costly and time-consuming burden of going to court.”

    OPIC reiterated those concerns in its Report to the 89th Texas Legislature, listing appraisal as its first recommendation, restating its previous position and adding, “Restrictions on appraisal can remove an important consumer protection that saves the parties and the judicial system time and resources. Appraisal is usually the consumer’s only economically realistic option for challenging the amount an insurer offers to repair or replace property. Filing a lawsuit is expensive – often more expensive than the amount of an auto repair claim. Eliminating appraisal leaves the consumer stuck in the middle of a dispute between the insurer and providers over the amount of loss, resembling the balance billing trap that health insurance consumers found themselves in before the Legislature addressed that issue.” They recommended that legislators “amend the Texas Insurance Code to require personal auto and residential property insurers in Texas to preserve the insurance consumer’s right to invoke appraisal in disputes regarding the cost to repair or replace covered property.”

    While McDorman stood at the forefront of the battlefield on this important issue, he had an entire army marching with him, throwing one stone at a time to combat this egregious violation of consumer rights.

    The Auto Body Association of Texas (ABAT) stood shoulder to shoulder with McDorman, providing pecuniary support and volunteering time and energy to promote all three iterations of the proposed mandatory appraisal legislation. In addition to significant personal financial contributions, ABAT President Burl Richards joined McDorman in several meetings with TDI and appearances before legislative committees to express the significance of this undertaking. Consumer advocacy watchdog Texas Watch also offered valuable support throughout the process through its efforts to generate public awareness, help educate legislators and the compilation of Impact of Auto Appraisal (available at bit.ly/TXW-RTA), a report that demonstrated the monetary affect that Right to Appraisal typically has on claim settlements.

    McDorman humbly credits the passage of Senate Bill 458 to Joe Collins, whose experience with the appraisal process yielded a large settlement from State Farm (see bit.ly/CollinsvSF). Recognizing how detrimental a similar under-indemnification situation might be for others, especially those who do not have the protections provided through the Appraisal Clause, Collins donated his entire settlement to the fight for mandatory appraisal rights. “If that money goes toward making sure all Texas policies include the Right to Appraisal, then I’m helping everybody.” (Full story available at bit.ly/Collins4RTA.) Collins entrusted the funds to Auto Claim Specialists and McDorman who used them to establish the Mandatory Appraisal Rights Advocacy Trust.

    Collins’ story inspired many others from across the country to contribute to a GoFundMe fundraiser, creating a national movement. “Joe’s generosity and dedication to ‘doing the right thing’ resonated with people, and they wanted to support our efforts,” McDorman offers praise and gratitude to everyone who contributed to the fight. “Many people helped us get to where we are, but Joe’s donation was instrumental to building that momentum. I’m gratified by the passage of the bill which demonstrates that I was a worthy steward of his trust.”

    Countless others aided in achieving this victory for mandatory appraisal rights as well. Other public adjusters, multiple law firms and lobbyists stepped up, donating time, money and energy to support the cause.

    McDorman’s own contributions are unquantifiable. Beyond the financial commitment he made personally and on behalf of Auto Claim Specialists, he spent thousands of hours away from the business, devoted to compiling data to present to legislators to help them understand why their constituents deserve the Right to Appraisal.

    “The devil is in the detail,” he explains. “Every time I shared information, I had the evidence to support it. The insurance industry tends to be a little less transparent with their reporting, which provides the opportunity for dishonesty and undervaluation; I put a microscope on that practice and demonstrated how often policyholders get cheated. Now, all of our legislators understand how this provision protects their constituents, and I commend them for doing what’s right for all Texans, to help ensure safe roadways. The fact that the vote was unanimous from the House and the Senate – across both sides of the aisle – proves what a great job we did educating them on how the Appraisal Clause is a vital mechanism to ensure vehicle owners are reimbursed for all the operations required to safely repair their cars.”

    He equates the legislative victory with the concept of slaying a giant. “We went up against really big odds; the insurance industry has deep pockets which enables them to walk all over people most of the time. Often, that happens because we are afraid to fight them; we’re afraid to lose. But when you’re doing the right thing for the right reason, it’s worthwhile to keep going, to continue the fight to make a difference. That’s what we did, and our efforts paid off – this was the people’s fight…and the people fought and WON!”

    Senate Bill 458, which seeks to ensure that all Texas insurance policies “must contain an appraisal provision” and specifies that this appraisal provision “is intended to provide a type of dispute resolution process solely to determine the amount of loss when that amount is in dispute between the policyholder and the insurer,” will go into effect on September 1, 2025. (Read the bill in its entirety at bit.ly/SB458text.)

    McDorman is ecstatic that all Texas policyholders will soon have access to the vital protection of Right to Appraisal, and he “looks forward to the next step, working with TDI to establish guidelines and appropriate time triggers.”

    ###

    Auto Claim Specialists is a national public insurance adjuster agency dedicated to ensuring consumers receive a fair settlement on their auto claims. Founded in 2017 by consumer advocate Robert McDorman, Auto Claim Specialists seeks to hold insurers accountable for fully indemnifying their policyholders for damages suffered by establishing the true value of losses. More information can be found online at autoclaimspecialists.com or by calling 817-756-5482.

    For further information, please contact: claims@autoclaimspecialists.com

    Contact Information

    Thomas Greco
    thomas@grecopublishing.com
    9736676922

    .

    SOURCE: Auto Claim Specialists

    View the original press release on ACCESS Newswire

  • Jaguar Health Provides Updates on Orphan Disease Intestinal Failure Development Program for Crofelemer

    Jaguar Health Provides Updates on Orphan Disease Intestinal Failure Development Program for Crofelemer

    Enrollment in company’s first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for microvillus inclusion disease (MVID) in pediatric patients has reached approximately 25%

    As recently announced, initial proof-of-concept results of the ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in patients with intestinal failure due to MVID and short bowel syndrome by up to 27% and 12.5% respectively; data from the third patient enrolled is expected

    Company strategy: Seek business development partnerships for license to develop and commercialize Jaguar’s intestinal failure products, resulting in non-dilutive funding for Jaguar

    SAN FRANCISCO, CA / ACCESS Newswire / June 23, 2025 / Jaguar Health, Inc.(NASDAQ:JAGX) (Jaguar) today provided updates on the company’s orphan disease intestinal failure program. Jaguar, through Jaguar family companies Napo Pharmaceuticals (Napo) and Napo Therapeutics, is currently supporting two independent proof-of-concept investigator-initiated trials (IITs), and conducting two placebo-controlled Phase 2 studies, of crofelemer, Jaguar’s novel plant-based anti-secretory prescription drug, in patients with intestinal failure due to microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF) in the United States, European Union, and/or Middle East/North Africa regions.

    As announced, and as presented April 26, 2025 at the Annual ELITE PED-GI Congress, initial proof-of-concept results from the ongoing exploratory, single-arm open label non-randomized IIT of crofelemer in Abu Dhabi in pediatric intestinal failure patients show that crofelemer reduced the required total parenteral nutrition (TPN) and supplementary intravenous fluids in the first participating MVID patient by up to 27% and in the first participating SBS-IF patient by up to 12.5%. In addition, this data showed that crofelemer reduced stool volume output and/or frequency of watery stools, and increased urine output – an indicator of improved nutrient oral absorption. Data from the third patient enrolled in the IIT is expected.

    Completion of Napo’s randomized double-blind, placebo-controlled Phase 2 study of crofelemer in pediatric MVID patients is expected in mid-2026 as planned.

    “Our strategy is to seek business development partnerships for license rights for development and commercialization of Jaguar’s intestinal failure products – with the goal of generating non-dilutive funding for Jaguar,” said Lisa Conte, Jaguar’s Founder and CEO. “I attended the BIO International Convention in Boston last week and took part in productive meetings at the event.”

    “Given the ultrarare nature of MVID, and the groundbreaking initial proof-of-concept results from the ongoing IIT in Abu Dhabi, even a small number of MVID patients showing benefit with crofelemer may allow Napo to explore pathways for expedited regulatory approval,” said Conte.

    “We’re excited to report that enrollment in the company’s first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for MVID in pediatric patients is at approximately 25% and patient screening is continuing. For the company’s placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for SBS-IF in adults, enrollment is above 10%, and patient screening is continuing,” said Conte. “Additionally, enrollment is continuing in the two ongoing proof-of-concept IITs. These are important milestones in development efforts for crofelemer for the treatment and management of intestinal failure related to these devastating orphan diseases and will continue to generate IIT data.”

    Based on the initial findings of the ongoing IIT in Abu Dhabi, crofelemer’s paradigm-shifting antisecretory mechanism of action appears to have the potential to provide a novel therapeutic option to reduce TPN and associated complications, including liver, renal, and cognitive deficits, as well as infections from IV infusion, in patients with intestinal failure due to MVID and short bowel syndrome. The observed groundbreaking TPN reduction is particularly compelling for MVID, an ultrarare pediatric disease characterized by severe diarrhea and malabsorption that requires intensive parenteral support for nutritional and fluid management and for which no approved drug treatments exist, or any potential approach to reduce TPN.

    The initial proof-of-concept data in MVID supports crofelemer’s potential inclusion in the European Medicines Agency’s (EMA) PRIMEprogram that may accelerate regulatory approval pathways in the EU. This data may also support qualification of crofelemer for the FDA’s Breakthrough Therapyprogram for expedited regulatory approval in the US. Additional proof-of-concept results from IITs are expected throughout 2025 and will provide additional preliminary data on the safety and potential effectiveness of crofelemer for these highly unmet clinical needs. In accordance with the guidelines of specific EU countries, published data from clinical investigations in MVID and SBS-IF could support reimbursed early patient access to crofelemer for these debilitating conditions.

    About Crofelemer
    Crofelemer is a novel, oral plant-based prescription medicine purified from the red bark sap, also referred to as “dragon’s blood,” of the Croton lechleri tree in the Amazon Rainforest. Napo Pharmaceuticals has established a sustainable harvesting program, under fair trade practices, for crofelemer to ensure a high degree of quality, ecological integrity, and support for indigenous communities.

    About the Jaguar Health Family of Companies
    Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases. Jaguar Animal Health is a Jaguar tradename. Magdalena Biosciences, a joint venture formed by Jaguar and Filament Health Corp. that emerged from Jaguar’s Entheogen Therapeutics Initiative(ETI), is focused on developing novel prescription medicines derived from plants for mental health indications.

    For more information about:
    Jaguar Health, visit https://jaguar.health/
    Napo Pharmaceuticals, visit www.napopharma.com
    Napo Therapeutics, visit napotherapeutics.com
    Magdalena Biosciences, visit magdalenabiosciences.com

    Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram

    Forward-Looking Statements
    Certain statements in this press release constitute “forward-looking statements.” These include statements regarding Jaguar’s expectation that completion of Napo’s Phase 2 study of crofelemer in pediatric MVID patients will occur mid-2026, Jaguar’s expectation that the two ongoing proof-of-concept IITs will continue to generate data, Jaguar’s expectation that data from the third patient enrolled in the IIT in Abu Dhabi is expected, Jaguar’s expectation that its strategy of seeking business development partnerships for license rights for development and commercialization of Jaguar’s intestinal failure products may support generation of non-dilutive funding for Jaguar, Jaguar’s expectation that even a small number of MVID patients showing benefit with crofelemer may allow Napo to explore pathways for expedited regulatory approval of crofelemer for MVID, Jaguar’s expectation that crofelemer’s mechanism of action may have the potential to provide a novel therapeutic option to reduce TPN and associated complications, including liver, renal, and cognitive deficits, as well as infections from IV infusion, in pediatric MVID and SBS-IF patients, Jaguar’s expectation that proof-of-concept data in MVID may support crofelemer’s potential inclusion in the EMA’s PRIME program for expediated and assisted regulatory approval and in the FDA’s Breakthrough Therapy program for expedited regulatory approval in the US, Jaguar’s expectation that additional proof-of-concept results from IITs will be available throughout 2025, and Jaguar’s expectation that published data from clinical investigations in MVID and SBS-IF could support reimbursed early patient access to crofelemer for MVID and SBS-IF. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “aim,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar’s control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

    Contact:
    hello@jaguar.health
    Jaguar-JAGX

    SOURCE: Jaguar Health, Inc.

    View the original press release on ACCESS Newswire

  • Updated Lineup Announced for iAccess Alpha’s Virtual Summer Investment Conference, June 24–25, 2025

    Updated Lineup Announced for iAccess Alpha’s Virtual Summer Investment Conference, June 24–25, 2025

    RALEIGH, NC / ACCESS Newswire / June 23, 2025 / iAccess Alpha’s Virtual Best Ideas Summer Investment Conference will take place on June 24-25, 2025, bringing together top micro-cap companies and investors for two days of high-quality insights and investing opportunities. The lineup has recently been updated to include additional presenters.

    The event begins on Tuesday, June 24, 2025, with a series of live-streamed company presentations, beginning at 9:00 AM ET. The following day, Wednesday, June 25, will be dedicated to 1×1 meetings between presenting companies and investors, starting at 8:00 AM ET.

    How to Attend:

    Investors and industry professionals can register to watch the presentations and request 1×1 meetings by visiting the official event website: Register Here

    Conference Schedule – June 24, 2025 (All Times ET):

    Time

    Company

    Ticker

    Webcast Link

    9:00am

    Inuvo Inc.

    NYSE/AMEX:INUV

    View Presentation

    9:30am

    Digi Power X Inc.

    NASDAQ:DGXX /TSXV:DGX

    View Presentation

    10:00am

    Surgepays Inc.

    NASDAQ:SURG

    View Presentation

    10:30am

    Coya Therapeutics Inc.

    NASDAQ:COYA

    View Presentation

    11:00am

    MIND Technoloy Inc.

    NASDAQ:MIND

    View Presentation

    11:30am

    Data IO Corp.

    NASDAQ:DAIO

    View Presentation

    12:00pm

    Gaia Inc.

    NASDAQ:GAIA

    View Presentation

    12:30pm

    Upexi Inc.

    NASDAQ:UPXI

    View Presentation

    1:00pm

    DocGo Inc.

    NASDAQ:DCGO

    View Presentation

    1:30pm

    SKYX Platforms Corp.

    NASDAQ:SKYX

    View Presentation

    2:00pm

    HeartBeam Inc.

    NASDAQ:BEAT

    View Presentation

    2:30pm

    Heritage Global Inc.

    NASDAQ:HGBL

    View Presentation

    3:00pm

    Mobilicom Ltd.

    NASDAQ:MOB

    View Presentation

    3:30pm

    Envela Corp.

    NYSE/AMEX:ELA

    View Presentation

    About iAccess Alpha’s Virtual Best Ideas Investment Conferences

    iAccess Alpha hosts four virtual investment conferences annually (March, June, September, and December), showcasing high-potential small and micro-cap investment opportunities. The conferences feature live company presentations on Day 1, followed by exclusive 1×1 investor meetings on Day 2. Since 2019, iAccess Alpha has co-organized leading microcap-focused events, connecting top-tier investors with high-potential companies.

    For more information, contact:
    info@iaccessalpha.com
    www.iaccessalpha.com

    SOURCE: iAccess Alpha

    View the original press release on ACCESS Newswire

  • ZeptoMetrix Launches H5N1 Control With Phage-Like Particle (PLP) Technology

    ZeptoMetrix Launches H5N1 Control With Phage-Like Particle (PLP) Technology

    BUFFALO, NEW YORK / ACCESS Newswire / June 23, 2025 / ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A H5N1 Quantitative Stock, a groundbreaking advancement in molecular diagnostic quality assurance. Leveraging phage-like particle encapsulated RNA technology, this product sets a new standard for accuracy and reliability in avian influenza (H5N1) detection, addressing critical gaps in laboratories’ ability to validate end-to-end testing workflows.

    As H5N1 outbreaks continue to rise globally, the need for robust quality control materials has never been greater. ZeptoMetrix’s Influenza A H5N1 Quantitative Stock offers laboratories a comprehensive quality control material that requires RNA extraction, unlike traditional naked RNA products. This novel solution includes three encapsulated H5N1 gene segments within a phage-like particle, ensuring realistic validation of extraction, amplification, and detection steps.

    “The ongoing H5N1 pandemic highlighted the urgent need for reliable diagnostic tools,” said Dr. Karuna Sharma, PhD, Vice President & Chief Scientific Officer of Antylia Diagnostics division. “This launch represents a significant advancement in diagnostic quality control. By encapsulating RNA within a phage-like particle, we enable labs to have confidence in their results at every step. This is not just innovation; it is vital in the fight against H5N1 and other emerging RNA viruses.”

    NATtrol Influenza A H5N1 Quantitative Stock (Product Code: 0831198) is NATtrol inactivated to enhance stability and provided with precision quantification at 1,000,000 gene copies/mL of each gene segment, verified by digital PCR (dPCR). The ready-to-use 1 mL format integrates seamlessly with ZeptoMetrix’s -STQ product line, streamlining workflow adoption.

    More information on how to order and additional ZeptoMetrix products can be found at: www.zeptometrix.com

    About ZeptoMetrix®

    ZeptoMetrix, an Antylia Scientific company, is an established industry leader in the design, development, and delivery of innovative, quality solutions to the infectious disease diagnostics market. Our expertise and abilities in molecular diagnostics, including external quality controls, verification panels, proficiency panels, customized and OEM products/services, have set the industry standard for performance and reliability and make ZeptoMetrix the preferred choice for independent third-party quality control materials.

    Product Page: https://www.zeptometrix.com/us/en/nattrol-influenza-a-h5n1-quantitative-stock-1-x-10-ml-15355

    Contact Information

    Andrew Zenger
    Global Product Manager
    andrew.zenger@antylia.com
    (716) 715-7417

    .

    SOURCE: ZeptoMetrix

    View the original press release on ACCESS Newswire

  • Seafood Industry Leader Luke’s Lobster Closes Strategic Growth Equity Financing

    Seafood Industry Leader Luke’s Lobster Closes Strategic Growth Equity Financing

    PORTLAND, ME / ACCESS Newswire / June 23, 2025 / Luke’s Lobster, the Certified B Corp known for its best‑in‑class, traceable, and sustainable seafood, today announced closing on a minority growth equity financing led by Relentless Consumer Partners with participation from Whole Foods Market.

    Luke's Lobster
    Luke’s Lobster
    Luke’s Lobster logo

    “Since day one, Luke’s has been laser‑focused on building transparent supply chains that deliver industry leading value to the harvesters, cut out middlemen, and offer premium seafood at the best price to our customers. Our vision is to become the world’s most trusted seafood company and this investment is a validation and accelerant towards achieving that mission,” said Luke Holden, founder & CEO of Luke’s Lobster. “Closing on this funding coming from such highly value-added investors provides significant financial resources as well as customer-facing expertise to continue growth in our restaurants, branded consumer packaged goods, and wholesale seafood lines of business.”

    Relentless Consumer Partners, an investment firm specializing in brands who redefine the consumer experience, identified Luke’s Lobster as a leader in sustainably sourced seafood and consumer loyalty, with a substantial untapped opportunity for growth. “Luke’s checks every box: exceptional product quality, unwavering mission, and a passionate customer base,” noted John Burns, CEO at Relentless Consumer Partners. “We’re thrilled to help support Luke and the team in accelerating the next phase of growth without compromising the brand’s core values.”

    For Whole Foods Market, participation in the investment round deepens the relationship with Luke’s Lobster, a longstanding supplier for the retailer who was awarded top honors in 2018 as Whole Foods Market’s Supplier of the Year, and sets the stage for Luke’s Lobster to continue the growth of their seafood business as a whole including across a variety of seafood species beyond lobster. “Our customers consistently look to Whole Foods Market for an unparalleled seafood selection that meets our rigorous standards for sustainability and quality, as well as our Seafood Code of Conduct,” said Jennifer Coccaro, Vice President of Meat & Seafood for Whole Foods Market. “We look forward to what’s next for Luke’s Lobster, and continuing our longstanding collaboration with a brand that is beloved by our stores and customers.”

    The investment capital will expand Luke’s Lobster’s branded consumer packaged goods product offerings and distribution footprint, support new restaurant openings around the country, and drive innovation and growth within the seafood industry as a whole.

    Under the terms of the transaction, Luke’s current leadership team will maintain day‑to‑day operational control, while Relentless Consumer Partners and Whole Foods Market will provide strategic guidance and resources.

    ###

    About Luke’s Lobster

    Luke’s Lobster was born out of the dream of Maine native and third-generation lobsterman Luke Holden to bring the quality, affordable lobster rolls of his youth to NYC. After meeting his co-founder Ben Conniff on Craigslist, the two twenty-somethings, along with Luke’s dad, Jeff Holden, who is the very first licensed lobster processor in the state of Maine opened their first lobster shack in a 250 square foot space in NYC’s East Village in October 2009. Nearly 16 years later, the family business now includes Luke’s brothers Bryan and Mike.

    In 2018, Luke’s furthered their growing seafood company’s commitment to sustainability and socially conscious business practices by becoming a certified B Corporation®, reflecting Luke’s Lobster’s deep devotion to each of its communities, its family of teammates, and the environment. Luke’s is now the highest scoring B Corp Certified seafood company in the US, and in 2024 was a recipient of Travel + Leisure’s Global Vision Award. Please visit www.lukeslobster.com for more information.

    About Relentless Consumer Partners

    Relentless acquires and invests in high-potential consumer brands, taking an active role in driving outsized shareholder returns. We have a relentless devotion to supporting entrepreneurs as they push the boundaries between passion and obsession, and we are fanatical about elevating products, services, and experiences that empower people to live better lives. For two decades we have partnered with extraordinary founders and teams to build brands that are redefining consumer experience across health, wellness, consumer healthcare, sports and fitness. For more information visit www.relentlessconsumer.com.

    Contact Information

    Carla Tracy
    PR/Communications
    carla@carlatracypr.com
    646-591-7126

    .

    SOURCE: Luke’s Lobster

    View the original press release on ACCESS Newswire

  • LQR House Announces Upcoming Strategic Marketing Collaboration With Whiplash Whiskey Ahead of Summer Launch

    LQR House Announces Upcoming Strategic Marketing Collaboration With Whiplash Whiskey Ahead of Summer Launch

    MIAMI BEACH, FL / ACCESS Newswire / June 23, 2025 / LQR House Inc. (the “Company” or “LQR House”) (NASDAQ:YHC), a niche ecommerce platform specializing in the spirits and beverage industry, is pleased to announce a new marketing agreement with Whiplash Whiskey. Under the agreement, LQR House will launch a custom digital multi-platform marketing campaign. Such campaign is intended to support the summer debut of Whiplash’s latest product – a whipped cream-flavored whiskey.

    Whiplash Whiskey described its products as redefining indulgence with a bold twist, combining the smoothness of premium whiskey with the nostalgic richness of whipped cream. It’s a spirit that blurs the line between dessert and drink, making it an ideal candidate for viral content and consumer intrigue.

    LQR House will leverage its robust network of influencers, creators, and digital assets to position Whiplash Whiskey as a summer staple. The campaign will be executed through LQR House’s proprietary e-commerce platform, CWSpirits.com, with a focus on driving brand awareness, customer engagement, and direct-to-consumer sales.

    “At LQR House, we look for brands that break through the noise, and Whiplash Whiskey is exactly that,” said Sean Dollinger, CEO of LQR House. “We believe that this product embodies the kind of innovation that resonates with today’s consumers-playful, unexpected, and built for shareability. We intend to amplify this launch through curated content, influencer storytelling, and high-conversion e-commerce strategies. We’re excited to help Whiplash make a bold entrance this summer.”

    This collaboration continues LQR House’s mission to align with forward-thinking beverage brands that prioritize creativity, quality, and direct consumer connection. Whiplash Whiskey will be available for purchase on CWSpirits.com starting this summer.

    About LQR House Inc.

    LQR House intends to become a prominent force in the wine and spirits e-commerce sector, epitomized by its flagship alcohol marketplace, cwspirits.com. This platform seamlessly delivers a diverse range of emerging, premium, and luxury spirits, wines, and champagnes from esteemed retail partners like Country Wine & Spirits. Functioning as a technology-driven hub, LQR House utilizes software, data analytics, and artificial intelligence to elevate consumer experience. CWSpirits.com stands out as the go-to destination for modern, convenience-oriented shoppers, providing a curated selection of alcohol products delivered to homes across the United States. Beyond its role in an e-commerce sector, LQR House is a marketing agency with a specialized focus on the alcohol industry. The Company measures campaign success by directly correlating it with sales on CWSpirits.com, demonstrating a return on investment. Backed by an influential network of around 460 figures in the alcohol space, LQR House strategically drives traffic to CWSpirits.com, enhancing brand visibility. LQR House intends to disrupt the traditional landscape of the alcohol industry, driven by its dedication to providing an unparalleled online purchasing experience and delivering tailored marketing solutions.

    Forward-Looking Statements

    Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Shareholders can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. Forward-looking statements contained in this press release are made only as of the date of this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in other reports and documents that the Company files from time to time with the United States Securities and Exchange Commission (the “SEC”). You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the headings “Risk Factors”. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in other reports and documents that the Company files from time to time with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. References and links to websites have been provided as a convenience, and the information contained on such websites has not been incorporated by reference into this press release.

    Investor and Media Contact:
    info@lqrhouse.com

    SOURCE: LQR House

    View the original press release on ACCESS Newswire

  • Dateline Resources Reports Strong Progress in Colosseum Gold-REE Exploration Program in California

    Dateline Resources Reports Strong Progress in Colosseum Gold-REE Exploration Program in California

    SAN BERNARDINO, CA / ACCESS Newswire / June 23, 2025 / Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF), an Australian-based exploration company, is pleased to provide an update on its ongoing exploration program at the 100%-owned Colosseum Gold and Rare Earth Elements (REE) Project, located in the prolific Walker Lane Trend of San Bernardino County, California. This comprehensive program highlights Dateline’s commitment to advancing the exploration of this dual-commodity asset through detailed geophysical and geochemical surveys.

    The magneto telluric (MT) geophysical survey is progressing steadily, with data collected from 119 of the planned 167 stations, representing approximately 70% completion. Designed to capture deep subsurface resistivity data along multiple lines spanning the project claims, the MT survey aims to image geological structures and alteration zones that could indicate buried breccia pipes or REE-bearing mineralized features. Preliminary 1D and 2D resistivity inversions from the first three completed survey lines have been generated and are under review by Dateline’s technical team, showing resistivity contrasts that may correlate with key lithological contacts or structural features at depth. A full 3D inversion of the MT dataset will be conducted once all field data is collected, with results expected within 2-4 weeks of survey completion, enhancing the company’s ability to pinpoint high-priority drill targets.

    In parallel, the geochemical sampling program is advancing, with 599 of the planned 1,207 samples, roughly 50%, collected as of today. Targeting high-priority areas such as newly identified felsite dykes west of historic pits and untested gravity-low anomalies to the east, these samples are being sent to the laboratory in batches for multi-element analysis, including a full suite of rare earth elements, to identify geochemical anomalies and pathfinder elements. Initial assay results from the first batch are expected in early July 2025, with comprehensive interpretation to follow once all samples are analyzed. Given current progress, terrain, and temperature conditions, the sampling campaign is anticipated to conclude in approximately 17-20 days.

    These exploration efforts are central to Dateline’s “stacked evidence” methodology, which integrates MT, geochemical, gravity, and potentially ground magnetic data to refine drill targets. The results will guide upcoming drilling campaigns, including a maiden REE-focused program, positioning Colosseum as a strategically significant project for both gold and critical minerals.

    Located less than 10 kilometers north of the world-class Mountain Pass REE mine, the Colosseum Project is well-positioned to capitalize on the growing global demand for rare earth elements, supported by strong U.S. government initiatives to bolster domestic production. This positions the project to contribute to America’s strategic mineral supply chain, enhancing national security by reducing reliance on foreign sources of critical minerals.

    Managing Director Stephen Baghdadi commented, “We are very encouraged by the field progress and initial data coming from Colosseum. In just a short period, our team has covered roughly half of the geochemical survey grid, and the MT survey is advancing on schedule. Each batch of samples sent to the lab and each line of geophysical data brings us a step closer to uncovering the next phase of Colosseum’s potential. We look forward to receiving the assay results in July along with the MT survey’s 3D models. Combining these new datasets will allow us to pinpoint the most prospective zones for both gold and rare earths with a high degree of confidence. This systematic approach is laying the groundwork for our upcoming drilling campaigns, including the maiden REE-focused drill program, to unlock value from this unique gold-REE project.”

    About Dateline Resources Limited

    Dateline Resources Limited (ASX: DTR, OTCQB: DTREF) is an Australian company focused on mining and exploration in North America. The Company owns 100% of the Colosseum Gold-REE Project in California.

    The Colosseum Gold Mine is located in the Walker Lane Trend in East San Bernardino County, California. On 6 June 2024, the Company announced to the ASX that the Colosseum Gold mine has a JORC-2012 compliant Mineral Resource estimate of 27.1Mt @ 1.26g/t Au for 1.1Moz. Of the total Mineral Resource, 455koz @ 1.47/t Au (41%) are classified as Measured, 281koz @1.21g/t Au (26%) as Indicated and 364koz @ 1.10g/t Au (33%) as Inferred.

    On 23 May 2025, Dateline announced that updated economics for the Colosseum Gold Project generated an NPV6.5 of US$550 million and an IRR of 61% using a gold price of US$2,900/oz.

    The Colosseum is located less than 10km north of the Mountain Rare Earth mine. Planning has commenced on drill testing the REE potential at Colosseum.

    Forward-Looking Statements

    This announcement may contain “forward-looking statements” concerning Dateline Resources that are subject to risks and uncertainties. Generally, the words “will”, “may”, “should”, “continue”, “believes”, “expects”, “intends”, “anticipates” or similar expressions identify forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Many of these risks and uncertainties relate to factors that are beyond Dateline Resources’ ability to control or estimate precisely, such as future market conditions, changes in regulatory environment and the behavior of other market participants. Dateline Resources cannot give any assurance that such forward-looking statements will prove to have been correct. The reader is cautioned not to place undue reliance on these forward-looking statements. Dateline Resources assumes no obligation and does not undertake any obligation to update or revise publicly any of the forward-looking statements set out herein, whether as a result of new information, future events or otherwise, except to the extent legally required.

    Competent Person Statement

    Sample preparation and any exploration information in this announcement is based upon work reviewed by Mr Greg Hall who is a Chartered Professional of the Australasian Institute of Mining and Metallurgy (CP-IMM). Mr Hall has sufficient experience that is relevant to the style of mineralization and type of deposit under consideration and to the activity which he is undertaking to quality as a Competent Person as defined in the 2012 Edition of the “Australasian Code for Reporting Exploration Results, Mineral Resources and Ore Reserves” (JORC Code). Mr Hall is a Non-Executive Director of Dateline Resources Limited and consents to the inclusion in the report of the matters based on this information in the form and context in which it appears.

    Contact Information
    Stephen Baghdadi
    Managing Director
    Dateline Resources Limited
    +61 2 9375 2353
    info@datelineresources.com.au
    www.datelineresources.com.au

    Andrew Rowell
    White Noise Communications
    +61 400 466 226
    andrew@whitenoisecomms.com

    Follow Dateline on X: @Dateline_DTR

    Dateline Resources Limited
    Level 29, 2 Chifley Square, Sydney, NSW 2000, Australia

    This press release is authorized for release by the Board of Dateline Resources Limited

    SOURCE: Dateline Resources Limited

    View the original press release on ACCESS Newswire

  • Side Hustles Can Mean Big Tax Trouble – Clear Start Tax Shares How to Avoid IRS Penalties

    Side Hustles Can Mean Big Tax Trouble – Clear Start Tax Shares How to Avoid IRS Penalties

    Clear Start Tax Breaks Down Common Filing Mistakes, Hidden Income Triggers, and What Freelancers Can Do to Avoid IRS Trouble

    IRVINE, CA / ACCESS Newswire / June 23, 2025 / Millions of Americans now rely on gig work, freelance jobs, and side hustles to make ends meet, but many don’t realize they’re creating a hidden tax burden in the process. According to Clear Start Tax, side income can quickly trigger IRS scrutiny if it’s not reported properly, especially in today’s digital economy, where third-party platforms automatically report your earnings.

    Whether it’s driving for a rideshare service, selling on Etsy, or offering contract work through Upwork, the IRS considers that income taxable, and failure to report it accurately can lead to audits, penalties, and growing tax debt.

    “Side hustle income is real income in the eyes of the IRS,” said the Head of Client Solutions at Clear Start Tax. “And with the 1099 rules getting stricter, many taxpayers are being caught off guard by back taxes and enforcement actions they didn’t see coming.”

    Where Side Hustlers Get Into Trouble

    Clear Start Tax identifies the most common tax pitfalls freelancers run into, including:

    • Missing or Misunderstood 1099s – Payments over $600 from platforms like Venmo, Etsy, or Uber are often reported directly to the IRS, even if the taxpayer doesn’t receive a paper form.

    • No Estimated Payments – Many gig workers don’t realize they’re required to pay taxes quarterly. Skipping these payments can lead to underpayment penalties.

    • Improper Deductions – Overstating business expenses – or not claiming legitimate ones – can trigger audit flags.

    • Failure to Report Cash or App Income – Cash jobs and payments from Zelle, PayPal, or other apps are still taxable, even if no 1099 is issued.

    The IRS is getting more aggressive with digital income tracking, added the Head of Client Solutions at Clear Start Tax. “Without proactive reporting and planning, even a modest side job can create a major tax issue.”

    By answering a few simple questions, taxpayers can find out if they’re eligible for the IRS Fresh Start Program and take the first step toward resolving their tax debt.

    How IRS Algorithms Flag Side Income in 2025

    With enhanced data-matching systems and tighter 1099-K thresholds, the IRS is cracking down on unreported income tied to third-party platforms. In 2025, many taxpayers will receive 1099-Ks for gross payments over $5,000 – and in some states, the threshold is even lower.

    Clear Start Tax notes that many gig workers are unaware of these updates until they receive an unexpected IRS letter months after tax season.

    How to Stay Compliant – and Out of Trouble

    Clear Start Tax recommends that side income earners take the following steps to avoid IRS penalties:

    • Track Every Dollar: Use a bookkeeping app or spreadsheet to log all income and expenses in real time.

    • Make Quarterly Payments: Use IRS Form 1040-ES to submit estimated taxes and avoid large year-end bills.

    • Don’t Ignore IRS Notices: Even small underpayment letters can snowball into enforcement actions if left unaddressed.

    • Get Professional Help: If you’ve fallen behind or are unsure about how to file, it’s better to get help before penalties increase.

    How Clear Start Tax Helps Side Hustlers in Trouble

    Clear Start Tax works with freelancers, gig workers, and small business owners to resolve tax debt, correct unfiled returns, and negotiate relief through programs like Offer in Compromise or Currently Not Collectible status. Their team begins with a full IRS transcript review to understand each client’s exposure, then creates a customized plan to halt collections and get compliant again.

    “When side income leads to IRS trouble, it’s easy to feel overwhelmed,” said the Head of Client Solutions at Clear Start Tax. “We work with clients to get ahead of enforcement, correct past mistakes, and build a plan that protects their future income.”

    With IRS enforcement rising in 2025, informed gig workers who act early have the best chance at avoiding penalties and resolving tax issues quickly.

    About Clear Start Tax

    Clear Start Tax is a full-service tax liability resolution firm that serves taxpayers throughout the United States. The company specializes in assisting individuals and businesses with a wide range of IRS and state tax issues, including back taxes, wage garnishment relief, IRS appeals, and offers in compromise. Clear Start Tax helps taxpayers apply for the IRS Fresh Start Program, providing expert guidance in tax resolution. Fully accredited and A+ rated by the Better Business Bureau, the firm’s unique approach and commitment to long-term client success distinguish it as a leader in the tax resolution industry.

    Need Help With Back Taxes?

    Click the link below:
    https://clearstarttax.com/qualifytoday/
    (888) 710-3533

    Contact Information

    Clear Start Tax
    Corporate Communications Department
    seo@clearstarttax.com
    (949) 535-1627

    SOURCE: Clear Start Tax

    View the original press release on ACCESS Newswire

  • Arrive AI Celebrates Nasdaq Debut by Ringing Opening Bell with Early Supporters, Pioneering the Future of Autonomous Delivery

    Arrive AI Celebrates Nasdaq Debut by Ringing Opening Bell with Early Supporters, Pioneering the Future of Autonomous Delivery

    INDIANAPOLIS, INDIANA / ACCESS Newswire / June 23, 2025 / Arrive AI (NASDAQ:ARAI) – a pioneering autonomous delivery network anchored by Arrive Points™ – is set to mark a pivotal moment in its journey by ringing Nasdaq’s opening bell on July 3, 2025. More than 300 of the company’s foundational investors, alongside team members, will join the celebration, highlighting the incredible support that fueled Arrive AI’s ascent to the public market.

    “This isn’t just about ringing a bell; it’s a testament to the vision and unwavering belief of our early investors who stood with us every step of the way,” said Arrive CEO Dan O’Toole. “This landmark achievement is for everyone who joined our journey and made this moment possible. We are the real ‘we the people’ story!”

    Arrive AI officially began publicly trading on May 15, 2025.

    The company is rapidly transforming the autonomous delivery landscape with its Arrive Points, intelligent, networked smart mailboxes that serve as universal access points for both traditional and autonomous deliveries. This proprietary network offers an ever-growing suite of services, ranging from real-time data tracking, smart logistics alerts and advanced chain of custody controls to support shippers, delivery services and autonomous networks. The system seamlessly integrates with smart home devices such as doorbells, lighting and security systems, to streamline and secure the entire last-mile delivery experience.

    O’Toole’s journey from designing the prototype Arrive Point on a napkin to ringing the Nasdaq bell began in 2014 when he sought U.S. Patent Office protection for his smart mailbox design. In doing so, he edged out Amazon by four days and other industry leaders by weeks. He secured that foundational patent in 2017 and has continued to refine the product and has also developed an AI-driven network and platform.

    Arrive AI now holds eight patents for its proprietary technology. Six additional patents are pending. Arrive AI has a total of 58 patents pending for its ALM solution filed across 22 countries and has secured several trademarks. See details at https://www.arriveai.com/intellectual-property.

    The latest patent highlights the Arrive Points’ cutting-edge capabilities, including:

    • Climate control: Ensuring the integrity of sensitive deliveries,

    • Battery charging and exchange station: Supporting the evolving needs of autonomous vehicles,

    • Advanced safety features: A collector for identifying explosive materials and anthrax, and ultraviolet and ozone applicators to eradicate disease, viruses and harmful materials, and

    • Comprehensive monitoring: Weather monitoring; vehicle and package tracking; facial recognition camera and software for both humans and pets; local two-way speakers; and integrated flood light and strobe LED lighting.

    Arrive AI is actively collaborating with leaders in the healthcare industry where efficiency, accuracy and security are paramount for deliveries. O’Toole emphasizes the platform’s vast potential for data tracking and other services, solidifying its position as a universal access point for the entire autonomous logistics industry.

    -30-

    About Arrive AI: Arrive AI’s patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox, whether by drone, ground robot or human courier. The platform provides real-time tracking, smart logistics alerts and advanced chain of custody controls to support shippers, delivery services and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting and security systems to streamline the entire last-mile delivery experience. Learn more at www.arriveai.com.

    Media contact: Cheryl Reed at media@arriveai.com.

    Investor Relations Contact: Alliance Advisors IR at ARAI.IR@allianceadvisors.com.

    Cautionary Note Regarding Forward Looking Statements 

    This news release and statements of Arrive AI’s management in connection with this news release or related events contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “potential”, “will”, “should”, “could”, “would” ,”optimistic” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI’s public filings for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

    SOURCE: Arrive AI Inc.

    View the original press release on ACCESS Newswire

  • Who Will Governor DeSantis Support: Big Land Developer or Residents?

    Who Will Governor DeSantis Support: Big Land Developer or Residents?

    VENICE, FLORIDA / ACCESS Newswire / June 23, 2025 / Recent articles highlight concerns over developers increasingly utilizing special taxing districts in Florida, which can serve residents, but lately appear to be granting developers excessive control. A key example is CS/HB 4061 – West Villages Improvement District, Sarasota County. This bill, passed with expedient unanimity through the Florida Legislature, awaited being sent to the Governor for nearly two months amid Wellen Park resident protests including a Change.org petition that now has 3,177 signatures urging a veto.

    On its face, the bill adjusts thresholds for transitioning WVID board seats in from developer-appointed to resident-elected. Currently, the district’s board has four developer-appointed and one resident-elected seat, but ongoing litigation by a few residents claims that they deserve one or two more elected seats already. CS/HB 4061 would render resident these claims moot, whether they were valid before or not. Rep. Danny Nix, the bill’s sponsor, made a statement on March 26 to the House Intergovernmental Affairs Committee that putting an end to the resident litigation was an intent with the bill.

    Residents claim the new thresholds are unrealistic, ensuring developer control indeterminately, control including tax-billed assessment fees paid to the developer’s entity for up to 100 years for holding a water permit. More alarmingly, though, the bill grants the district eminent domain powers and the ability to annex land without government approval, allowing a foreign-owned corporation’s employees to force easements, seize private property, and expand the district indefinitely.

    CS/HB 4061 bypasses officials meant to manage growth and protect resources, enabling unsustainable development. At a June 17 12th District Court hearing, the developer’s attorney suggested a 100-year water agreement is irrelevant due to impending water shortages, implying the development knowingly exceeds local resource capacity.

    Residents fear a for-profit, foreign-owned company will control tax assessments, profit from them, and dictate resource management and growth, leaving Floridians to bear future costs. The bill’s passage raises broader concerns about developer-driven districts undermining local governance and straining resources without oversight.

    In 2023, DeSantis dissolved Disney’s special district, Reedy Creek Improvement District, stating, “Allowing a corporation to control its own government is bad policy, especially when the corporation makes decisions that impact an entire region…” Unlike Reedy Creek, where Disney uses the land in perpetuity as a long-term stakeholder (for theme parks, hotels, amenities, etc.), The WVID’s foreign-owned master developer makes their profit by selling off the land piece-by-piece over time. They are not a stationary, long-term stakeholder in the region. One could think that the same quote would be even more relevant.

    With CS/HB 4061 sent to DeSantis in the extended session’s final hours, only a few days remain. Signing or ignoring the bill, which becomes law automatically if not acted upon, supports the developer. A veto is the only hope for the district’s residents, with their 3,177 petitioners among 9,972 registered voters, who seek protection from unchecked corporate control. DeSantis’ choice will reveal whether he prioritizes voting citizens or a foreign-owned developer’s interests.

    Contact Information

    Ali Johnston
    Freelance Writer, Wellen Park Florida resident
    ali-johnston@live.com
    941-539-5771

    .

    SOURCE: Florida resident

    View the original press release on ACCESS Newswire